PHARMACOKINETICS OF THE LONG-ACTING CEFTIOFUR CRYSTALLINE-FREE ACID IN ARABIAN SHE-CAMELS (Camelus dromedarius)
DOI:
https://doi.org/10.26873/SVR-1074-2020Abstract
Ceftiofur is an important broad-spectrum 3rd generation cephalosporin antibiotic. Owing to its time-dependent antimicrobial actions, the length of time of being above bacterial MIC is the critical point in using ceftiofur for chemotherapy rather than its peak of concentration. Consequently, this experiment was carried out to evaluate, for the first time, the pharmacokinetics of the long-acting ceftiofur crystalline acid-free form (ceftiofur-CAF) in camels. Ceftiofur-CAF 200 mg/ml suspension sterile solution was injected i/m at a dose 6.6 mg/kg. Blood samples were collected from the jugular vein in vacutainer tubes at 0, 0.13, 0.25, 0.5, 1, 2, 4, 8, 12, 24, 48, 72, 96, 120, and 144 hours after administration of the drug. Ultrahigh Performance Liquid Chromatography-Mass Spectrometry (UPLC MS/MS) was used to measure serum concentration. Pharmacokinetic modeling was by a two-compartment model. Pharmacokinetics of ceftiofur-CAF after single i/m injection in she-camels was best modeled in the two-compartment model, where the drug slowly distributed to a second compartment with poor tissue penetration and high preference to the central compartment. In this study, the maximum plasma concentration (Cmax) was 9.29±0.42 μg/ml at Tmax equals 9.41±1.35 h. The area under the curve (AUC0-∞) was 354.1±57.22 μg/ml*h. The distribution and elimination half-lives were 7.42 and 46.13 h, respectively. The mean residence time (MRT) was 42.01 h. Compared with the rapidly absorbed form of ceftiofur (ceftufor-RAF) in camels, there was almost similar maximal serum concentration but with delayed time to maximal concentration (Tmax), longer means residence time (MRT) and higher distribution and elimination half-lives. In terms of antibacterial efficacy, ceftiofur-CAF stayed above a previously recommended level of 0.2 μg/ml for 7 days, which can be achieved after a single i/m injection of 6.6 mg/kg. The obtained pharmacokinetics data in camels recommends repeated administration of 2 days apart for bacteria requiring MIC levels above 2 μg/ml.
Key words: Ceftiofur; pharmacokinetics; camel; cephalosporins
FARMAKOKINETIKA DOLGODELUJOČE CEFTIOFURNE KRISTALINIČNE PROSTE KISLINE PRI SAMICAH ARABSKIH KAMEL (Camelus dromedarius)
Izvleček: Ceftiofur je pomemben širokospektralni antibiotik 3. generacije cefalosporinov. Zaradi njegovih časovno odvisnih protimikrobnih učinkov je čas, ko je raven ceftiofura nad bakterijskim MIC in ne pri njegovem vrhu koncentracije kritična točka pri uporabi tega antibiotika. Poskus je bil izveden z namenom ovrednotenja farmakokinetike dolgo delujoče ceftiofurjeve kristalinične brezkislinske oblike (ceftiofur-CAF) pri kamelah. Ceftiofur-CAF v koncentraciji 200 mg/ml suspenzije sterilne raztopine smo injicirali i/m v odmerku 6,6 mg/kg. Vzorci krvi so bili zbrani iz vratne vene v vakuumskih epruvetah ob injiciranju antibiotika in nato 8, 15 in 30 minut po injiciranju ter 1, 2, 4, 8, 12, 24, 48, 72, 96, 120 in 144 ur po injiciranju antibiotika. Za merjenje serumske koncentracije je bila uporabljena tekočinska kromatografija ultra visoke ločljivosti (UPLC MS/MS). Farmakokinetično modeliranje je bilo izvedeno z dvokomponentnim modelom. Farmakokinetiko ceftiofur-CAF-a po enkratnem i/m injiciranju v kamele je bilo najbolje modelirati v modelu z dvema predelkoma, kjer se je zdravilo počasi razdeljevalo v drugi predelek s slabo penetracijo v tkiva in veliko prednostjo do osrednjega predelka. Najvišja koncentracija antibiotika v plazmi (Cmax) je bila 9,29 ± 0,42 μg/ml pri Tmax 9,41 ± 1,35 ure. Površina pod krivuljo (AUC0-∞) je bila 354,1 ± 57,22 μg/ml*h. Razpolovni čas razporeditve in izločanja je bil 7,42 oziroma 46,13 ure. Povprečni čas prisotnosti antibiotika (MRT) je bil 42,01 h. V primerjavi s hitro absorbirano obliko ceftiofurja (ceftufor-RAF) pri kamelah je bila skoraj podobna največja koncentracija v serumu, vendar z zakasnjenim časom do največje koncentracije (Tmax), daljšim časom zadrževanja (MRT) in večjim razpolovnim časom porazdelitve in izločanja. Ceftiofur-CAF ostal dni nad predhodno priporočeno ravnijo učinkovitosti 0,2 μg/ml kar 7 dni, kar je bilo mogoče doseči po enkratni i/m injekciji 6,6 mg/kg. Pridobljeni podatki o farmakokinetiki v kamelah priporočajo večkratno dajanje v razmaku 2 dni za bakterije, ki potrebujejo ravni MIC nad 2 μg/ml.
Ključne besede: Ceftiofur; farmakokinetika; kamela; cefalosporini
References
Collard W, Cox S, Lesman S, et al. Pharmacokinetics of ceftiofur crystalline‐free acid sterile suspension in the equine. J Vet Pharmacol Ther 2011; 34: 476–81.
(2.) Oliver S, Gillespie B, Headrick S, et al. Efficacy of extended ceftiofur intramammary therapy for the treatment of subclinical mastitis in lactating dairy cows. J Dairy Sci 2004; 87: 2393–400.
(3.) Hall T, Tell L, Wetzlich S, McCormick J, Fowler L, Pusterla N. Pharmacokinetics of ceftiofur sodium and ceftiofur crystalline free acid in neonatal foals. J Vet Pharmacol Ther 2011; 34: 403–9.
(4.) Al-Tarazi Y. Bacteriological and pathological study on pneumonia in the one-humped camel (Camelus dromedarius) in Jordan. Rev Elevage Med 2001; 54: 93–7.
(5.) Abbas B, Omer O. Review of infectious diseases of the camel. Vet Bull 2005; 75: 1–16.
(6.) Doré E, Angelos JA, Rowe JD, et al. Pharmacokinetics of ceftiofur crystalline free acid after single subcutaneous administration in lactating and nonlactating domestic goats (Capra aegagrus hircus). J Vet Pharmacol Ther 2011; 34: 25–30.
(7.) Hibbard B, Robb EJ, Chester JS, Dame KJ, Moseley WW, Bryson WL. Dose determination and confirmation for ceftiofur crystalline-free acid administered in the posterior aspect of the ear for control and treatment of bovine respiratory disease. Vet Ther 2002; 3: 22–30.
(8.) Salyards GW, Knych HK, Hill AE, Kelly KR, Christe KL. Pharmacokinetics of ceftiofur crystalline free acid in male rhesus macaques (Macaca mulatta) after subcutaneous administration. J Am Assoc Lab Anim Sci 2015; 54: 557–63.
(9.) Waldoch JA, Cox SK, Armstrong DL. Pharmacokinetics of a single intramuscular injection of long-acting ceftiofur crystalline-free acid in cattle egrets (Bubulcus ibis). J Avian Med Surg 2017; 31: 314–9.
(10.) Legrand T, Vodovar D, Tournier N, Khoudour N, Hulin A. Simultaneous determination of eight beta-lactam antibiotics, amoxicillin, cefazolin, cefepime, cefotaxime, ceftazidime, cloxacillin, oxacillin, and piperacillin, in human plasma by using ultra-high-performance liquid uchromatography with ultraviolet detection. Antimicrob Agents Chemother 2016; 60: 4734–42.
(11.) Wang J, Fan X, Liu Y, et al. Extraction optimization of sixteen cephalosporins in milk by filtered solid-phase extraction and ultra high-pressure liquid chromatography coupled to tandem mass spectrometry. Anal Methods 2017; 9: 1282–9.
(12.) Hou XL, Wu YL, Lv Y, Xu XQ, Zhao J, Yang T. Development and validation of an ultra-high-performance liquid chromatography-tandem mass spectrometry method for determination of 10 cephalosporins and desacetylcefapirin in milk. J Chromatogr B Anal Technol Biomed Life Sci 2013; 931: 6–11.
(13.) Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814–20.
(14.) Amatya R. Multi-class, multi residue method for determination of penicillins, cephalosporins, and quinolones in cow milk and validation in accordance with Commission Decision 2002/657/EC. Barcelona : University of Barcelona, 2010. (European Masters in Quality in Analytical Laboratories)
(15.) Shrivastava A, Gupta VB. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron Young Sci 2011; 2: 21.
(16.) Zhang Y, Huo M, Zhou J, Xie S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 2010; 99: 306–14.
(17.) Goudah A. Pharmacokinetics of ceftiofur after single intravenous and intramuscular administration in camels (Camelus dromedarius). J Vet Pharmacol Ther 2007; 30: 371–4.
(18.) Rivera-Garcia S, Angelos JA, Rowe JD, et al. Pharmacokinetics of ceftiofur crystalline-free acid following subcutaneous administration of a single dose to sheep. Am J Vet Res 2014; 75: 290–5.
(19.) Tell L, Harrenstien L, Wetzlich S, et al. Pharmacokinetics of ceftiofur sodium in exotic and domestic avian species. J Vet Pharmacol Ther 1998; 21: 85–91.
(20.) Wojick KB, Langan JN, Adkesson MJ, Cox SK, Gamble KC. Pharmacokinetics of long-acting ceftiofur crystalline-free acid in helmeted guineafowl (Numida meleagris) after a single intramuscular injection. Am J Vet Res 2011; 72: 1514–8.
(21.) Kilburn JJ, Cox SK, Backues KA. Pharmacokinetics of ceftiofur crystalline free acid, a long-acting cephalosporin, in American flamingos (Phoenicopterus ruber). J Zoo Wildl Med 2016; 47: 457–62.
(22.) Adkesson MJ, Fernandez-Varon E, Cox S, Martín-Jiménez T. Pharmacokinetics of a long-acting ceftiofur formulation (ceftiofur crystalline free acid) in the ball python (Python regius). J Zoo Wildl Med 2011; 42: 444–50.
(23.) Tang S, Xiao J, Guo G, He J, Hao Z, Xiao X. Preparation of a newly formulated long‐acting ceftiofur hydrochloride suspension and evaluation of its pharmacokinetics in pigs. J Vet Pharmacol Ther 2010; 33: 238–45.
(24.) Quintiliani R. Pharmacodynamics of antimicrobial agents: time-dependent vs concentration-dependent killing. http://www.antimicrobe.org/h04c.files/history/PK-PD%20Quint.asp (March, 2021)
